Commercialization, • 9/19/25 Real-World Evidence That Matters: A Hands-On Workshop in Building Credible Value Stories Previous What Matters to Payers: Conversations You Should Start During Phase 2 Next Conducting Rare Disease Clinical Trials to Support Market Access and Commercialization You Might Also Like Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development Accelerating Rare Disease Therapies: Strategies for Efficient Clinical Development Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials Aligning Trials with Patient-Lived Experiences
Commercialization, • 9/19/25 Real-World Evidence That Matters: A Hands-On Workshop in Building Credible Value Stories Previous What Matters to Payers: Conversations You Should Start During Phase 2 Next Conducting Rare Disease Clinical Trials to Support Market Access and Commercialization You Might Also Like Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development Accelerating Rare Disease Therapies: Strategies for Efficient Clinical Development Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials Aligning Trials with Patient-Lived Experiences
